Exit Options for John Hancock Bond and Corporate Finance Group: Hanover Communications In... - 28 Strategic Investors
- or -
Your request has been sent. Someone from the Aurigin team will be in touch with you shortly.
Please connect with us to get access to Impact Vault
Hungary
US$10M to 500M
More than 50%, 100%
US$5M to 200M
US$1M to 20M
Direct Party
Hungarian based Pharma company looking to acquire companies having new therapeutic systems including cardiovascular, Central nervous system, Gastroenterology, dermatology and gynecology (OTC & RX), Oncology, Bio-similar drugs(autoimmune, oncology and onco-hematology). Preferably With 10% and above EBITDA.